African-American Heart Failure Trial

This study has been completed.
Sponsor:
Information provided by:
Nitromed
ClinicalTrials.gov Identifier:
NCT00047775
First received: October 18, 2002
Last updated: June 23, 2005
Last verified: October 2004

October 18, 2002
June 23, 2005
May 2001
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00047775 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
African-American Heart Failure Trial
Not Provided

A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure.

The overall objective is confirmation of BiDil’s Safety and Efficacy in African-American (AFA) Patients with Moderate to Severe Symptomatic Heart Failure.

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Congestive Heart Failure
Drug: BiDil
Not Provided
Mitchell JE, Tam SW, Trivedi K, Taylor AL, O'Neal W, Cohn JN, Worcel M. Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT). Am Heart J. 2011 Jul;162(1):154-9. doi: 10.1016/j.ahj.2011.04.022.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1100
August 2004
Not Provided
  • African American male or female 18 years or older.
  • NYHA Class 3 & 4.
  • Have either a resting LVEF less than or equal to 35% (by any method) or a resting LVIDD greater than 2.9 cm/m2 BSA (or greater than 6.5 cm) with LVEF less than 45% (by echocardiogram).
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00047775
A-HeFT
Not Provided
Not Provided
Nitromed
Not Provided
Study Chair: Anne L. Taylor, M.D. University of Minnesota - Clinical and Translational Science Institute
Nitromed
October 2004

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP